Sequenom Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 434

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $379M

Sequenom General Information

Description

Provider of genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders. The company provides nucleic acid analysis platform that measures genetic target material and variations.

Contact Information

Website
www.sequenom.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3595 John Hopkins Court
  • San Diego, CA 92121
  • United States
Primary Industry
Monitoring Equipment
Acquirer
Laboratory Corporation of America
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 3595 John Hopkins Court
  • San Diego, CA 92121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sequenom Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Merger/Acquisition 07-Sep-2016 $379M 00000 00000 Completed Profitable
17. Debt Refinancing 18-Jun-2015 0000 00000 Completed Profitable
16. Debt - General 20-Sep-2012 00000 00000 Completed Profitable
15. 2PO 25-Jan-2012 0000 00000 Completed Profitable
14. Debt - General 02-Jun-2011 0000 00000 Completed Profitable
13. PIPE 21-May-2010 000.00 00000 Completed Profitable
12. PIPE 23-Dec-2009 00.000 00000 Completed Profitable
11. PIPE 09-Mar-2009 00.000 00000 Completed Profitable
10. PIPE 19-Nov-2008 $3.6M $247M Completed Profitable
9. Secondary Transaction - Open Market 01-Aug-2008 $244M Completed Profitable
To view Sequenom’s complete valuation and funding history, request access »

Sequenom Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders. The company prov
Monitoring Equipment
San Diego, CA
434 As of 2015
00000
00000 0000-00-00
000000&0 00000

000000

t dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
0000000000 000000000
Boston, MA
00 As of 0000
00000
000000 - 000 00000

000000

magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labori
0000000000 000000000
San Diego, CA
0000 As of 0000
00.000
000000000 00 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sequenom Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Seaport Diagnostics Venture Capital-Backed Boston, MA 00 00000 000000 - 000 00000
Illumina Formerly VC-backed San Diego, CA 0000 00.000 000000000 00 00.000
OncoDNA Venture Capital-Backed Gosselies, Belgium 000 000.00 00000000000 000.00
Natera Formerly VC-backed Austin, TX 0000 00000 00000000 00000
To view Sequenom’s complete competitors history, request access »

Sequenom Patents

  • 1,091

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 551

    Granted

  • 124

    Pending

  • 000

    Expiring in next 12 mo

Sequenom Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4150074-A1 Methods, systems, and compositions for the analysis of cell-free nucleic acids Pending 14-May-2020 000000000
CA-3183597-A1 Methods, systems, and compositions for the analysis of cell-free nucleic acids Pending 14-May-2020 000000000
US-20230220484-A1 Methods, systems, and compositions for the analysis of cell-free nucleic acids Pending 14-May-2020 000000000
CA-3159786-A1 Application of mosaicism ratio in multifetal gestations and personalized risk assessment Pending 31-Oct-2019 000000000
EP-4052259-A1 Application of mosaicism ratio in multifetal gestations and personalized risk assessment Pending 31-Oct-2019 G16B20/10
To view Sequenom’s complete patent history, request access »

Sequenom Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sequenom Former Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Comvest Partners PE/Buyout Minority 000 0000 000000 0
Delaware Crossing Investor Group Angel Group Minority 000 0000 000000 0
Fort Mason Capital PE/Buyout Minority 000 0000 000000 0
Global Life Science Ventures Venture Capital Minority 000 0000 000000 0
Haspa BGM PE/Buyout Majority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »

Sequenom Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SensiGen 27-Jan-2009 0000000000 00.00 Biotechnology 00000 000
Sequenom Center for Molecular Medicine 17-Nov-2008 Merger/Acquisition 000 Laboratory Services (Healthcare)
To view Sequenom’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Sequenom FAQs

  • When was Sequenom founded?

    Sequenom was founded in 1994.

  • Where is Sequenom headquartered?

    Sequenom is headquartered in San Diego, CA.

  • What is the size of Sequenom?

    Sequenom has 434 total employees.

  • What industry is Sequenom in?

    Sequenom’s primary industry is Monitoring Equipment.

  • Is Sequenom a private or public company?

    Sequenom is a Private company.

  • What is the current valuation of Sequenom?

    The current valuation of Sequenom is 00000.

  • What is Sequenom’s current revenue?

    The current revenue for Sequenom is 00000.

  • How much funding has Sequenom raised over time?

    Sequenom has raised $524M.

  • Who are Sequenom’s investors?

    Comvest Partners, Delaware Crossing Investor Group, Fort Mason Capital, Global Life Science Ventures, and Haspa BGM are 5 of 17 investors who have invested in Sequenom.

  • Who are Sequenom’s competitors?

    Seaport Diagnostics, Illumina, OncoDNA, and Natera are competitors of Sequenom.

  • When was Sequenom acquired?

    Sequenom was acquired on 07-Sep-2016.

  • Who acquired Sequenom?

    Sequenom was acquired by Laboratory Corporation of America.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »